Register for free to
view the full innovation profile.
Differentiate intra cellular components associated cancer progression and metastases development.
About
We are developing a multiplex antibody platform capable of monitoring a single binding event. Such single molecule detection is being validated in circulating tumour cell applications where it can differentiate intra cellular components associated cancer progression and metastases development. The patented platform technology has further applications in infectious disease testing and other settings that require multiplex diagnostics. We are is keen to hear form potential collaborators. When contacting us, please quote reference number 5012.